Carl Danzig, MD, is Director of Vitreoretinal Services at Rand Eye Institute in Deerfield Beach, Florida. He may be reached at carldanzigmd@gmail.com. Dr. Danzig has received research grants from 4DMT, Adverum, Genentech, IvericBio/Astellas, Novartis, Regeneron, and RegenxBio; is a consultant to Abbvie, Alimera, Galimedix, Genentech/Roche, IvericBio/Astellas, Kodiak, Novartis, Ophthea, Regeneron, and Regenxbio; and is a speaker for Genentech and IvericBio/Astellas.